# D.C. Cannabis Board Finalizes $3,000 Settlement and Permanent Closure of Flowerz > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/dc-cannabis-board-enforcement-actions-patient-access/ > **Published:** 2026-04-01T18:04:47-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:32:37-04:00 > **Clinical Summary:** D C Cannabis Board enforcement actions like the Flowerz closure affect patient access to legal cannabis in D.C. Learn about compliance and regulatory impacts. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Regulation[Patient Access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/)DispensaryComplianceD.C. Policy Why This Matters Regulatory enforcement actions like permanent dispensary closures directly impact [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to legal, tested cannabis products. When dispensaries close due to compliance failures, patients may be forced to seek products from unregulated sources with unknown safety profiles. Clinical Summary The D.C. Cannabis Board permanently closed Flowerz dispensary and imposed a $3,000 settlement for regulatory violations. While the specific violations are not detailed in the available information, such enforcement actions typically involve issues with product testing, labeling requirements, or operational compliance. Dispensary closures reduce the legal access points for registered patients in the jurisdiction. Dr. Caplan’s Take “When dispensaries close for compliance issues, I worry most about where my patients will turn next. A $3,000 fine suggests relatively minor violations, but permanent closure indicates the Board prioritized public safety over business continuity.” Clinical Perspective 🧠 Patients previously served by this dispensary should verify their remaining legal options in D.C. and ensure any new source provides properly tested products with clear labeling. Clinicians should be prepared to help patients navigate access disruptions and emphasize the importance of maintaining legal, regulated sources. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20D.C.%20Cannabis%20Board%20Finalizes%20%243%2C000%20Settlement%20and%20Permanent%20Closure%20of%20Flowerz%20%40drcaplan&url=https%3A//outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20D.C.%20Cannabis%20Board%20Finalizes%20%243%2C000%20Settlement%20and%20Permanent%20Closure%20of%20Flowerz%20--%20via%20%40drcaplan.bsky.social%20https%3A//outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/](https://outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What topics does this cannabis news cover?](#What_topics_does_this_cannabis_news_cover) - [Who publishes this clinical cannabis information?](#Who_publishes_this_clinical_cannabis_information) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How current is this cannabis news information?](#How_current_is_this_cannabis_news_information) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to rate cannabis-related news and developments on a scale of clinical importance. This particular item received rating #70 with “Notable Clinical Interest,” indicating emerging findings or policy developments that warrant close monitoring by healthcare professionals. #### What topics does this cannabis news cover? Based on the visible tags, this news item covers multiple important areas including regulation, patient access, dispensary operations, and compliance issues. These represent key areas of concern for both healthcare providers and patients in the [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) space. #### Who publishes this clinical cannabis information? This information appears to be published by CED Clinic, which seems to specialize in providing clinically relevant cannabis news and updates. They focus on delivering information that has direct relevance to healthcare practitioners and [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### What does “Notable Clinical Interest” mean for healthcare providers? A “Notable Clinical Interest” rating suggests that while this may not be groundbreaking research, it represents emerging findings or policy changes that could impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). Healthcare providers should monitor these developments as they may influence treatment protocols or regulatory compliance. #### How current is this cannabis news information? The article is marked as “New,” indicating it contains recently published or updated information. This ensures healthcare providers are receiving timely updates on cannabis-related developments that could affect their [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “D.C. Cannabis Board Finalizes $3,000 Settlement and Permanent Closure of Flowerz”, “url”: “https://outlawreport.com/d-c-cannabis-board-finalizes-3000-settlement-and-permanent-closure-of-flowerz/”, “datePublished”: “2026-04-01T18:25:45Z”, “about”: “d c cannabis board finalizes 3”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [St. Louis THC shop to shut down over illegal sales – FOX 2](https://cedclinic.com/illegal-cannabis-storefront-enforcement-st-louis/) Explore another case of cannabis dispensary closure due to regulatory violations and its impact on local patient access. [Read More](https://cedclinic.com/illegal-cannabis-storefront-enforcement-st-louis/) ['Slow as molasses:' Cannabis cultivators, applicants, decry licensing – The Providence Journal](https://cedclinic.com/rhode-island-cannabis-licensing-delays-impact-patient-access/) Learn about licensing challenges faced by cannabis businesses and how regulatory delays affect the industry. [Explore Article](https://cedclinic.com/rhode-island-cannabis-licensing-delays-impact-patient-access/) [DC cannabis operator files $1.6M lawsuit over failed cultivation buildout – Outlaw Report](https://cedclinic.com/commercial-cannabis-cultivation-failures-patient-access/) Understand legal disputes in the DC [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) related to regulatory and operational challenges. [Discover Details](https://cedclinic.com/commercial-cannabis-cultivation-failures-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).